March 3, 2026Open Access

Upregulation of NME4 is associated with progression and poor prognosis in clear cell renal cell carcinoma

Puntos clave

Upregulation of NME4 is associated with poor survival prognosis in clear cell renal cell carcinoma.
High NME4 expression levels correlate significantly with patients' clinical characteristics.
Assessment reveals NME4's role in tumorigenesis and its potential as a therapeutic target.
Future studies may uncover additional functionalities of NME4 in ccRCC progression.

Resumen

NME4 is highly expressed in ccRCC, and its expression levels are significantly associated with patients' clinical characteristics and survival prognosis. Meanwhile, experimental results indicate its important role in tumorigenesis and progression. NME4 has the potential to serve as a biomarker and therapeutic target for ccRCC.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Yanze Cheng

Lingling Xie

Zhejiang Chinese Medical University

Ningning Li

Nantong University

Journals

Translational Andrology and Urology

Actions

Institutions

Jiangsu University

Nantong University

Affiliated Hospital of Nantong University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Upregulation of NME4 is associated with progression and poor prognosis in clear cell renal cell carcinoma

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study